Archive
Proactive news snapshot: Green Dragon Gas, Ergomed, IXICO …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
Ergomed PLC
LON:ERGO
Ergomed PLC provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. The company's fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO).
204 stories · page 6 of 11
Petra Diamonds' shares sparkle after Tanzania lifts export ban
The government of Tanzania has given Petra the go-ahead to resume diamond exports and sales from the Williamson mine.
Ergomed unveils €5.7mln acquisition of Dutch-based PSR Group, part-funded by £2.9mln placing
The company completed the placing this morning, after an accelerated bookbuild, with 1.757576mln new ordinary shares issued at a price of 165p each
FTSE 100 closes up but optimism not "particularly high"
FTSE 100 ended in positive territory, having been lower earlier,..
Archive
Proactive news snapshot: Ergomed , PCF Group, Synairgen …
A glance at some of the day's highlights from the Proactive Investors newswire
Imaginatik lifted by contract win with US investment management company
"We continue to believe that in order for an organisation to build and sustain a business-critical innovation ethos and competency, technology and consultancy need to be implemented in a joined-up way," said Imaginatik
Ergomed signs first commercialisation deal for its blood coagulant products
The deal has been driven by British innovation in the treatment of surgical bleeding with multi-million dollar potential, Ergomed said
FTSE 100 steadily extends gains
There has been no news flow from FTSE 100 companies to speak of today
Archive
Proactive news snapshot: Jersey Oil & Gas, Flying Brands, Itaconix …
A glance at some of the day's highlights from the Proactive Investors newswire
Ergomed pleased with top-line growth in "solid first half"
Drug safety monitoring and medical information services are set for a year of out-performance
Archive
Focus shifts to US interest rates with Fed meeting; UK retail updates due from Kingfisher, Ocado
Week ahead includes Federal Reserve interest rate announcement, UK retail sales data, second quarter results from Kingfisher PLC, and trading update from Ocado PLC
New float Destiny Pharma's shares race to a 30% debut premium
The company, only the second biotech float this year, is bringing through a next-generation antibiotic
FDA gives Ergomed’s partner green light to resume phase III cancer study
The FDA placed a partial clinical hold on the trial back in September citing issues over the study’s design and safety
Archive
Proactive news snapshot: Rose Petroleum, CentralNic, Falcon Media House...
Some of today's headlines on the Proactive newswire
Ergomed completes recruitment for phase IIb study of PeproStat ahead of schedule
The drug development and pharma services company expects to report top line data from its study of PeproStat in the fourth quarter
Archive
Proactive end of day round-up: Cadence Minerals, Sound Energy, Brave Bison...
A summary of stories on the Proactive newswire today
Ergomed trial of blood thickener on the fast-track
Having reached the recruitment mid-point for coagulant PeproStat, it expects to deliver the first data from the study by the fourth-quarter of this year, rather than in the first three months of 2018
FTSE 100 closes in red as financial stocks hit
The index of blue-chip shares closed down 24.92 at 7,447
Archive
Proactive end of day round-up: Be Heard, BOS Global Holdings, Sirius Minerals...
A glance at some of the main stories on the Proactive newswire today